Literature DB >> 30251346

Modeled state-level estimates of hypertension prevalence and undiagnosed hypertension among US adults during 2013-2015.

Soyoun Park1, Cathleen Gillespie1, Jason Baumgardner2, Quanhe Yang1, Amy L Valderrama3, Jing Fang1, Fleetwood Loustalot1, Yuling Hong1.   

Abstract

Hypertension affects about one in three US adults, from recent surveillance, or four in nine based on the 2017 ACC/AHA Hypertension Guideline; about half of them have their blood pressure controlled, and nearly one in six are unaware of their hypertension status. National estimates of hypertension awareness, treatment, and control in the United States are traditionally based on measured BP from National Health and Nutrition Examination Survey (NHANES); however, at the state level, only self-reported hypertension awareness and treatment are available from BRFSS. We used national- and state-level representative samples of adults (≥20 years) from NHANES 2011-2014 and BRFSS 2013 and 2015, respectively. The authors generated multivariable logistic regression models using NHANES to predict the probability of hypertension and undiagnosed hypertension and then applied the fitted model parameters to BRFSS to generate state-level estimates. The predicted prevalence of hypertension was highest in Mississippi among adults (42.4%; 95% CI: 41.8-43.0) and among women (42.6%; 41.8-43.4) and highest in West Virginia among men (43.4%; 42.2-44.6). The predicted prevalence was lowest in Utah 23.7% (22.8-24.6), 26.4% (25.0-27.7), and 21.0% (20.0-22.1) for adults, men, and women, respectively. Hypertension predicted prevalence was higher in most Southern states and higher among men than women in all states except Mississippi and DC. The predicted prevalence of undiagnosed hypertension ranged from 4.1% (3.4-4.8; Kentucky) to 6.5% (5.5-7.5; Hawaii) among adults, from 5.0% (4.0-5.9; Kentucky) to 8.3% (6.9-9.7; Hawaii) among men, and from 3.3% (2.5-4.1; Kentucky) to 4.8% (3.4-6.1; Vermont) among women. Undiagnosed hypertension was more prevalent among men than women in all states and DC. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  blood pressure; hypertension; prevalence; state-level; undiagnosed hypertension; variance

Mesh:

Year:  2018        PMID: 30251346      PMCID: PMC8031025          DOI: 10.1111/jch.13388

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

1.  Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study.

Authors:  George Howard; Ron Prineas; Claudia Moy; Mary Cushman; Martha Kellum; Ella Temple; Andra Graham; Virginia Howard
Journal:  Stroke       Date:  2006-03-23       Impact factor: 7.914

2.  The "Million Hearts" initiative--preventing heart attacks and strokes.

Authors:  Thomas R Frieden; Donald M Berwick
Journal:  N Engl J Med       Date:  2011-09-13       Impact factor: 91.245

3.  Recall bias in epidemiologic studies.

Authors:  S S Coughlin
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

4.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

5.  CDC Grand Rounds: A Public Health Approach to Detect and Control Hypertension.

Authors:  Rikita Merai; Claudia Siegel; Michael Rakotz; Peter Basch; Janet Wright; Betty Wong; Phoebe Thorpe
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-18       Impact factor: 17.586

6.  Heat Maps of Hypertension, Diabetes Mellitus, and Smoking in the Continental United States.

Authors:  Matthew Shane Loop; George Howard; Gustavo de Los Campos; Mohammad Z Al-Hamdan; Monika M Safford; Emily B Levitan; Leslie A McClure
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-01

7.  Variables associated with change in blood pressure control status after 1-year follow up in primary care: a retrospective analysis: the TAPAS study.

Authors:  Carmen Suarez; Alberto Galgo; Teresa Mantilla; Manuel Leal; Carlos Escobar
Journal:  Eur J Prev Cardiol       Date:  2013-04-09       Impact factor: 7.804

8.  Comparison of examination-based and self-reported risk factors for cardiovascular disease, Washington State, 2006-2007.

Authors:  Juliet Van Eenwyk; Lillian Bensley; Eric M Ossiander; Karen Krueger
Journal:  Prev Chronic Dis       Date:  2012-06-21       Impact factor: 2.830

9.  Study design and participation rates of the New York City Health and Nutrition Examination Survey, 2004.

Authors:  Lorna E Thorpe; R Charon Gwynn; Jenna Mandel-Ricci; Sarah Roberts; Benjamin Tsoi; Lew Berman; Kathryn Porter; Yechiam Ostchega; Lester R Curtain; Jill Montaquila; Leyla Mohadjer; Thomas R Frieden
Journal:  Prev Chronic Dis       Date:  2006-06-15       Impact factor: 2.830

10.  Modeled state-level estimates of hypertension prevalence and undiagnosed hypertension among US adults during 2013-2015.

Authors:  Soyoun Park; Cathleen Gillespie; Jason Baumgardner; Quanhe Yang; Amy L Valderrama; Jing Fang; Fleetwood Loustalot; Yuling Hong
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-24       Impact factor: 3.738

View more
  9 in total

1.  Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.

Authors:  Eric Dietrich; Raj Desai; Mahek Garg; Haesuk Park; Steven M Smith
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-24       Impact factor: 3.738

2.  Racial/ethnic disparities in prevalence, treatment, and control of hypertension among US adults following application of the 2017 American College of Cardiology/American Heart Association guideline.

Authors:  Gulam Muhammed Al Kibria
Journal:  Prev Med Rep       Date:  2019-03-16

Review 3.  Hypertension in Women: A South-Asian Perspective.

Authors:  Fatima Farrukh; Amin Abbasi; Misbah Jawed; Aysha Almas; Tazeen Jafar; Salim S Virani; Zainab Samad
Journal:  Front Cardiovasc Med       Date:  2022-08-10

4.  Modeled state-level estimates of hypertension prevalence and undiagnosed hypertension among US adults during 2013-2015.

Authors:  Soyoun Park; Cathleen Gillespie; Jason Baumgardner; Quanhe Yang; Amy L Valderrama; Jing Fang; Fleetwood Loustalot; Yuling Hong
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-24       Impact factor: 3.738

5.  Burden of Undiagnosed Hypertension among Adults in Urban Communities of Southwest Ethiopia.

Authors:  Solomon Berhanu Mogas; Temamen Tesfaye; Belay Zewde; Yonas Tesfaye; Ayantu Kebede; Mulualem Tadesse; Esayas Kebede Gudina; Dessalegn Tamiru; Lelisa Sena Dadi
Journal:  Integr Blood Press Control       Date:  2021-05-21

6.  Undiagnosed hypertension in Peru: analysis of associated factors and socioeconomic inequalities, 2019.

Authors:  Delia Vanessa Guerrero-Díaz; Akram Hernández-Vásquez; Wency Cecilia Montoya-Rivera; Carlos Rojas-Roque; Manuel Alberto Chacón Díaz; Guido Bendezu-Quispe
Journal:  Heliyon       Date:  2021-07-09

7.  State and Regional Variation in Prescription- and Payment-Related Promoters of Adherence to Blood Pressure Medication.

Authors:  Peter K Yang; Matthew D Ritchey; Stavros Tsipas; Fleetwood Loustalot; Gregory D Wozniak
Journal:  Prev Chronic Dis       Date:  2020-09-24       Impact factor: 2.830

8.  Evaluation of US State-Level Variation in Hypertensive Disorders of Pregnancy.

Authors:  Alexander J Butwick; Maurice L Druzin; Gary M Shaw; Nan Guo
Journal:  JAMA Netw Open       Date:  2020-10-01

Review 9.  Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Chronic Kidney Disease: Are We There Yet?

Authors:  Alfonso Eirin; Lilach O Lerman
Journal:  Hypertension       Date:  2021-06-28       Impact factor: 9.897

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.